LRP2 Expression in Melanoma Is Associated With a Transitory Cell State, Increased T Cell Infiltration, and Is...

Area of Science:

• Molecular biology
• Cancer research
• Immunology

Background:

• Low density lipoprotein receptor-related protein 2 (LRP2) is an endocytic receptor found in developing and adult cells.
• LRP2 expression in epithelial cancers correlates with differentiation and improved prognosis.
• LRP2 is absent in benign nevi but frequently present in melanoma, necessitating investigation into its drivers and characteristics.

Purpose of the Study:

• To identify the molecular drivers of LRP2 expression in melanoma.
• To characterize LRP2-expressing melanoma cells.
• To explore the relationship between LRP2 expression and tumor microenvironment, specifically T cell inflammation and interferon-gamma signaling.

Main Methods:

• Analysis of LRP2 expression in melanoma samples.
• Transcriptional profiling to identify co-expressed gene programs.
• Investigation of interferon-gamma signaling pathways.
• Correlation of LRP2 expression with clinicopathological variables like Breslow thickness and clinical stage.

Main Results:

• Melanoma LRP2 expression is associated with a transient cell state co-expressing melanocyte and neural crest transcriptional programs.
• LRP2 expression is elevated in T cell-inflamed melanomas.
• Interferon-gamma directly upregulates LRP2 expression in melanoma cells.
• LRP2 expression in primary melanomas correlates with lower Breslow thickness and lower clinical stage.

Conclusions:

• LRP2 expression in melanoma is linked to a distinct cellular phenotype and a favorable prognostic profile.
• Interferon-gamma signaling is a key regulator of LRP2 expression in melanoma.
• Understanding LRP2 regulation provides insights into melanoma progression and potential therapeutic strategies.